Les-Martres-De-Veyre, France

Jacques A Simond


Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 60(Granted Patents)


Location History:

  • Chamalieres, FR (1976 - 1987)
  • Les Martres De Veyre, FR (1985 - 1989)

Company Filing History:


Years Active: 1976-1989

Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jacques A Simond

Introduction

Jacques A Simond is a notable inventor based in Les-Martres-De-Veyre, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of cardiovascular medicinal products. With a total of 14 patents to his name, Simond's work has had a considerable impact on pharmaceutical research.

Latest Patents

Among his latest patents, Simond has developed substituted 3-piperidinamines and 3-azepinamines. These compounds are characterized by specific formulas where R and R' denote alkyl or cycloalkyl radicals with 1 to 7 carbon atoms. The compounds also include various functional groups, such as halogeno and hydroxy, and are designed for application as cardiovascular medicinal products. His innovative approach has led to the creation of new substituted piperidine or azepine compounds, which also serve as potential cardiovascular treatments.

Career Highlights

Throughout his career, Jacques A Simond has worked with esteemed organizations, including the Centre Européen de Recherches Mauvernay. His research has focused on developing compounds that can significantly improve cardiovascular health. His dedication to innovation in medicinal chemistry has established him as a respected figure in the field.

Collaborations

Simond has collaborated with notable colleagues, including Andre J Monteil and Jacques Moleyre. These partnerships have fostered a collaborative environment that has enhanced the quality and scope of his research.

Conclusion

Jacques A Simond's contributions to medicinal chemistry, particularly in cardiovascular products, highlight his innovative spirit and dedication to improving health outcomes. His extensive patent portfolio reflects his commitment to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…